InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026)
InfuSystem Holdings (INFU) posted Cash from Investing Activities of -$1.3 million for Q1 2026, up 42.52% on a QoQ basis from -$2.2 million in Q4 2025, and up 52.65% year-over-year from -$825421.0 in Q1 2025.
InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- Quarterly Cash from Investing Activities rose 52.65% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (up 65.19% YoY) and the FY2025 annual result came in at -$6.8 million, up 48.71% from the prior year.
- Cash from Investing Activities was -$1.3 million for Q1 2026 at InfuSystem Holdings, up from -$2.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$252000.0 in Q3 2025 and bottomed at -$6.7 million in Q2 2024.
- A 5-year average of -$2.3 million and a median of -$2.3 million in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 91.43% — and 2024, when it sank 852.0%.
- InfuSystem Holdings' Cash from Investing Activities stood at -$3.1 million in 2022, then jumped by 65.79% to -$1.0 million in 2023, then sank by 213.12% to -$3.3 million in 2024, then jumped by 32.95% to -$2.2 million in 2025, then soared by 42.52% to -$1.3 million in 2026.
- Business Quant data shows INFU's Cash from Investing Activities at -$1.3 million in Q1 2026, -$2.2 million in Q4 2025, and -$252000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | InfuSystem Holdings | 188.97 Mn | 186.87 Mn | 19.68 Mn | -1.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.26 Mn |
| Mar 31, 2026 | -1.26 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Sep 30, 2025 | -252,000.00 |
| Sep 30, 2025 | -252,000.00 |
| Jun 30, 2025 | -1.69 Mn |
| Jun 30, 2025 | -1.69 Mn |
| Mar 31, 2025 | -2.66 Mn |
| Mar 31, 2025 | -2.66 Mn |
| Dec 31, 2024 | -3.27 Mn |
| Dec 31, 2024 | -3.27 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Jun 30, 2024 | -6.70 Mn |
| Jun 30, 2024 | -6.70 Mn |
| Mar 31, 2024 | -418,000.00 |
| Mar 31, 2024 | -418,000.00 |
| Dec 31, 2023 | -1.04 Mn |
| Dec 31, 2023 | -1.04 Mn |